Semaphorins and Their Receptors in Hematological Malignancies
Open Access
- 9 May 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 382
Abstract
While semaphorins were initially identified as axonal guidance cues for wiring the neural network, it was then recognized their wide relevance in tissue development and homeostasis. Notably, semaphorin activities were also extensively studied in many types of solid tumors; however, their relevance in hematological malignancies is far from understood. In this mini-review, we surveyed the current knowledge about semaphorins and their receptors in leukemias, lymphomas, and multiple myeloma. Noteworthy, current data support a promoting role for Semaphorin 4D and Neuropilin-1 in these tumors, while Semaphorin 3A seems to consistently act as oncosuppressor in leukemias and multiple myeloma. The expression levels and functional activities of SEMA3B, SEMA3F, and Neuropilin-2 have furthermore been investigated in leukemias and lymphoma cells. Herein, we reviewed the state of the art and highlighted some of the open questions to be addressed in the field.Keywords
This publication has 42 references indexed in Scilit:
- Semaphorins in cancer: Biological mechanisms and therapeutic approachesSeminars in Cell & Developmental Biology, 2013
- GLI1 regulates a novel neuropilin‐2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiationEMBO Molecular Medicine, 2013
- Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in miceJournal of Clinical Investigation, 2012
- Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor ModelsArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Targeting neuropilin-1 in human leukemia and lymphomaBlood, 2011
- Roles of Sema4D and Plexin-B1 in tumor progressionMolecular Cancer, 2010
- Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myelomaBlood, 2006
- Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemiaLeukemia, 2006
- CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytesBlood, 2003
- The Leukocyte Semaphorin CD100 Is Expressed in Most T-Cell, but Few B-Cell, Non-Hodgkin's LymphomasThe American Journal of Pathology, 1998